TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2022 it was $118.44K, up 372.8% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $118.44K | +372.8% |
| FY2021 | Dec 31, 2021 | $25.05K | – |
See a number that looks wrong?